Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,515 | 2 | 65.4% |
| Honoraria | $2,400 | 1 | 28.5% |
| Food and Beverage | $513.29 | 7 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| F. Hoffmann-La Roche AG | $5,515 | 2 | $0 (2019) |
| UROGEN PHARMA, INC. | $2,400 | 1 | $0 (2024) |
| Photocure Inc | $286.07 | 3 | $0 (2019) |
| Dendreon Pharmaceuticals LLC | $106.91 | 1 | $0 (2024) |
| Genentech, Inc. | $92.94 | 1 | $0 (2019) |
| Alnylam Pharmaceuticals Inc. | $13.69 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $13.68 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,507 | 2 | UROGEN PHARMA, INC. ($2,400) |
| 2022 | $13.69 | 1 | Alnylam Pharmaceuticals Inc. ($13.69) |
| 2019 | $5,777 | 5 | F. Hoffmann-La Roche AG ($5,515) |
| 2018 | $117.04 | 1 | Photocure Inc ($117.04) |
| 2017 | $13.68 | 1 | E.R. Squibb & Sons, L.L.C. ($13.68) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | UROGEN PHARMA, INC. | — | Honoraria | Cash or cash equivalent | $2,400.00 | General |
| 10/02/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $106.91 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/24/2022 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Genetic Disease | ||||||
| 12/31/2019 | F. Hoffmann-La Roche AG | TECENTRIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $5,063.41 | General |
| Category: BioOncology | ||||||
| 06/30/2019 | F. Hoffmann-La Roche AG | TECENTRIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $451.80 | General |
| Category: BioOncology | ||||||
| 06/30/2019 | Photocure Inc | Cysview (Drug) | Food and Beverage | In-kind items and services | $87.28 | General |
| Category: Oncology | ||||||
| 05/20/2019 | Photocure Inc | Cysview (Drug) | Food and Beverage | In-kind items and services | $81.75 | General |
| Category: Oncology | ||||||
| 05/04/2019 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $92.94 | General |
| 05/31/2018 | Photocure Inc | Cysview (Drug) | Food and Beverage | In-kind items and services | $117.04 | General |
| Category: Oncology | ||||||
| 07/10/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 529 | 656 | $2.0M | $112,437 |
| 2022 | 12 | 478 | 624 | $1.3M | $84,008 |
| 2021 | 12 | 384 | 504 | $1.2M | $75,054 |
| 2020 | 13 | 298 | 352 | $810,050 | $51,425 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 51595 | Removal of bladder and lymph nodes on both sides of pelvis with transplantation of ureters to small or large bowel with creation of urinary opening | Facility | 2023 | 25 | 25 | $729,734 | $39,685 | 5.4% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 25 | 25 | $313,300 | $19,194 | 6.1% |
| 55840 | Removal of prostate | Facility | 2023 | 25 | 25 | $313,300 | $11,092 | 3.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 125 | 211 | $257,315 | $10,545 | 4.1% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 32 | 36 | $111,960 | $7,301 | 6.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 71 | 71 | $35,095 | $6,181 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 85 | 109 | $23,795 | $4,954 | 20.8% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 15 | 15 | $156,420 | $3,631 | 2.3% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2023 | 12 | 12 | $53,484 | $3,248 | 6.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 43 | $13,528 | $2,781 | 20.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $9,317 | $1,882 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 28 | 28 | $9,708 | $1,588 | 16.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 42 | $1,470 | $352.80 | 24.0% |
| 51595 | Removal of bladder and lymph nodes on both sides of pelvis with transplantation of ureters to small or large bowel with creation of urinary opening | Facility | 2022 | 18 | 18 | $545,511 | $28,263 | 5.2% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 18 | 18 | $225,576 | $16,546 | 7.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 124 | 216 | $246,240 | $10,782 | 4.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 87 | 87 | $40,194 | $8,358 | 20.8% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2022 | 16 | 20 | $89,140 | $5,582 | 6.3% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2022 | 25 | 27 | $83,322 | $5,317 | 6.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 76 | 95 | $19,380 | $3,898 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 38 | 43 | $12,642 | $2,825 | 22.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 13 | 14 | $36,945 | $1,340 | 3.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 11 | 11 | $1,771 | $554.63 | 31.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 17 | 21 | $3,591 | $382.36 | 10.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 35 | 54 | $1,782 | $159.75 | 9.0% |
About Dr. Kyle Richards, M.D
Dr. Kyle Richards, M.D is a Urology healthcare provider based in Madison, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356524805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Richards, M.D has received a total of $8,429 in payments from pharmaceutical and medical device companies, with $2,507 received in 2024. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,515).
As a Medicare-enrolled provider, Richards has provided services to 1,689 Medicare beneficiaries, totaling 2,136 services with total Medicare billing of $322,924. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Madison, WI
- Active Since 12/06/2007
- Last Updated 01/19/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1356524805
Products in Payments
- TECENTRIQ (Biological) $5,515
- Cysview (Drug) $286.07
- PROVENGE (Drug) $106.91
- ONPATTRO (Drug) $13.69
- ELIQUIS (Drug) $13.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Madison
Dan Gralnek, Md, MD
Urology — Payments: $78,615
Christopher Manakas, M.d, M.D
Urology — Payments: $67,154
Matthew Grimes, M.d,, M.D,
Urology — Payments: $61,898
Javier Santiago, Md, MD
Urology — Payments: $56,891
Stephen Nakada, Md, MD
Urology — Payments: $21,895
Dr. Edwin Abel, M.d, M.D
Urology — Payments: $18,930